BeOne Medicines Ltd.
ONC
41 insider filings · Latest: Jun 23, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2026 | Jun 25 9:15 PM | Xiaobin WuPresident and COO | Sale | 1,292 | $276.26 | $356.9K | 0(D) | View → |
| Jun 23, 2026 | Jun 25 9:15 PM | John OylerDirector, Chief Executive Officer | Sale | 3,410 | $273.78 | $933.6K | 0(D) | View → |
| Jun 23, 2026 | Jun 25 9:14 PM | Lai WangPresident, Global Head of R&D | Sale | 1,068 | $276.74 | $295.6K | 0(D) | View → |
| Jun 23, 2026 | Jun 23 8:24 PM | LAI WANG | Proposed Sale | 1,068 | $276.74 | $295.6K | — | View → |
| Jun 23, 2026 | Jun 23 8:21 PM | XIAOBIN WU | Proposed Sale | 1,292 | $276.26 | $356.9K | — | View → |
| Jun 23, 2026 | Jun 23 8:13 PM | JOHN OYLER | Proposed Sale | 3,410 | $273.78 | $933.6K | — | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | Xiaobin WuPresident and COO | Sale | 1,357 | $266.76 | $362.0K | 0(D) | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | John OylerDirector, Chief Executive Officer | Sale | 3,693 | $265.55 | $980.7K | 0(D) | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | Chan Henry LeeSVP, General Counsel | Sale | 590 | $265.98 | $156.9K | 0(D) | View → |
| Jun 16, 2026 | Jun 18 9:19 PM | Lai WangPresident, Global Head of R&D | Sale | 1,169 | $265.39 | $310.2K | 0(D) | View → |
| Jun 16, 2026 | Jun 16 8:15 PM | CHAN LEE | Proposed Sale | 590 | $265.98 | $156.9K | — | View → |
| Jun 16, 2026 | Jun 16 8:14 PM | LAI WANG | Proposed Sale | 1,169 | $265.39 | $310.2K | — | View → |
| Jun 16, 2026 | Jun 16 8:12 PM | XIAOBIN WU | Proposed Sale | 1,357 | $266.76 | $362.0K | — | View → |
| Jun 16, 2026 | Jun 16 8:11 PM | JOHN OYLER | Proposed Sale | 3,693 | $265.55 | $980.7K | — | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Titus B. BallPrincipal Accounting Officer | Sale | 169 | $257.20 | $43.5K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Sale | 756 | $261.00 | $197.3K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Sale | 631 | $257.74 | $162.6K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Sale | 626 | $261.20 | $163.5K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Sale | 428 | $257.64 | $110.3K | 0(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Sale | 1,949 | $257.24 | $501.4K | 0(D) | View → |
Page 1 of 7
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Jun 15 9:55 PM | Lai WangPresident, Global Head of R&D | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Aaron RosenbergChief Financial Officer | Grant/Award | 137,865 | — | 137,865(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Xiaobin WuPresident and COO | Grant/Award | 229,775 | — | 229,775(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | Chan Henry LeeSVP, General Counsel | Grant/Award | 87,308 | — | 87,308(D) | View → |
| Jun 11, 2026 | Jun 15 9:55 PM | John OylerDirector, Chief Executive Officer | Grant/Award | 344,669 | — | 344,669(D) | View → |
| Jun 11, 2026 | Jun 15 9:54 PM | Xiaodong WangDirector, Other | Grant/Award | 193,492 | — | 193,492(D) | View → |
| May 13, 2026 | May 15 8:39 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 107,848(D) | View → |
| Apr 8, 2026 | Apr 10 9:40 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,316 | — | 109,122(D) | View → |
| Mar 11, 2026 | Mar 13 9:26 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 4,433 | — | 110,396(D) | View → |
| Feb 4, 2026 | Feb 6 9:57 PM | Chan Henry LeeSVP, General Counsel | Option Exercise | 21,580 | — | 111,670(D) | View → |